epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

vinagre de manzana

apple cider vinegar

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Entire Monograph

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • acne [Insufficient Evidence]
  • athletic performance [Insufficient Evidence]
  • atopic dermatitis (eczema) [Insufficient Evidence]
  • candidiasis, vulvovaginal [Insufficient Evidence]
  • cognitive function [Insufficient Evidence]
  • COVID-19 [Insufficient Evidence]
  • dandruff [Insufficient Evidence]
  • dental plaque [Insufficient Evidence]
  • depression [Insufficient Evidence]
  • diabetes mellitus, type 2 [Insufficient Evidence]
  • dyspepsia [Insufficient Evidence]
  • gastroparesis [Insufficient Evidence]
  • gingivitis [Insufficient Evidence]
  • herpes zoster (shingles) [Insufficient Evidence]
  • hyperlipidemia [Insufficient Evidence]
  • impaired glucose tolerance [Insufficient Evidence]
  • insect bite [Insufficient Evidence]
  • intestinal parasite infection [Insufficient Evidence]
  • leg cramps [Insufficient Evidence]
  • nephrolithiasis [Insufficient Evidence]
  • obesity [Insufficient Evidence]
  • osteoarthritis [Insufficient Evidence]
  • pharyngitis [Insufficient Evidence]
  • rhinosinusitis [Insufficient Evidence]
  • sunburn [Insufficient Evidence]
  • warts [Insufficient Evidence]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

dental plaque, peds patients

[Insufficient Evidence]
Dose: apply 5% solution topically qd; Info: for patients 3-6 yo

diabetes mellitus, type 2

[Insufficient Evidence]
Dose: 14-30 mL PO qd

gingivitis, peds patients

[Insufficient Evidence]
Dose: apply 5% solution topically qd; Info: for patients 3-6 yo

hyperlipidemia

[Insufficient Evidence]
Dose: 30 mL PO qd with meal; Info: may dilute with 100 mL water

obesity

[Insufficient Evidence]
Dose: 15 mL PO bid; Alt: 30 mL PO qd with meal; 5-15 mL PO qam given on empty stomach; Info: may dilute with 100-250 mL water

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information